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Abstract
Background: Allergy is a systemic, chronic and recurrent disorder of otorhinolaryngological importance. This
disorder is often neglected with late presentation in paediatric age group. This study aimed at determining the
prevalence, sociodemographic features, trigger factors, clinical features, complications, quality of life, associated co-
morbid illnesses and treatment outcome among children.
Materials and Methods: This was a prospective hospital based study of children with allergy in our center. The
study was carried out over a period of one year from May 2017 to April 2018. Data were obtained by using pretested
self-administered questionnaire. Data obtained were documented, collated and analyzed by using SPSS version
18.0
Results: Prevalence of allergy in this study was 8.6%. There were 60.2% male with male to female ratio of 1.5:1.
There was positive family history of allergy in 55.9% patients. Perennial allergy was the commonest in 68.3% of the
children. Major forms of allergens were 71.5% inhalant and 9.7% ingestant. The common self-reported trigger
factors were dust, cold weather and smoke in 58.1%, 41.9% and 22.0% respectively. Major associated comorbid
illnesses in this study were 43.5% adenotonsillar hypertrophy. Commonest allergic symptoms were runny nose in
38.7%. The commonest affected organ was nose in 46.8%. Commonly affected quality of life was 22.6% irritability,
20.4% absenteeism, 19.9% sleep disruption and 12.9% impaired social life. Common complications were 48.9%
secondary infection, 46.2% otitis media/externa, 44.1% injury, 42.5% foreign body impaction and 40.3% pharyngitis.
Treatment of allergy leads to improvement and recovery from the clinical features in 52.2%. No significant
improvement in 47.8%.
Conclusion: Allergy is a systemic disease affecting ear, nose and throat. It affects all paediatric age group with
associated comorbid illnesses, complications and affectation of quality of life at presentation in majority of the
patients.
Keywords: Otolaryngological; Allergy; Children; South western;
Nigeria
Introduction
Allergy is a hypersensitivity reaction initiated by immunological
mechanisms [1] and is usually IgE-antigen mediated hypersensitivity
reaction to the allergens [2]. It is a global public health problem with
prevalence of 20% to 40% worldwide and the trend is known to be on
increase [3-5]. In UK allergy affects up to 30% of adults and 40% of
children at some time in their lives [6,7]. Allergy is a chronic multi
organ disorder which involves inflammation of the mucous
membranes of the nose, sinuses, ear, pharynx, larynx, bronchus and
eyes in addition to the skin. This involves a complex interaction of
inflammatory mediators which is ultimately triggered by an
immunoglobulin E (IgE) [8]. This is mediated by response to an
intrinsic or extrinsic protein called allergens. The allergens include
house dust mites, pollen, cat, dog, and molds [9,10]. On exposure to
allergen, IgE is cross-linked, and this is the signal that leads to mast cell
degranulation in the mucous membrane [11-13].
In addition, assessing the comorbidities of allergic rhinitis may help
clinicians to recognize symptoms of allergic rhinitis to achieve early
and prompt treatment [14-16].
Poorly controlled allergy may also contribute to the development of
other related disease processes including sinusitis, recurrence of nasal
polyps, otitis media, hearing impairment, adenotonsillar hypertrophy
with sleep apnea and related complications, aggravation and increased
propensity to develop asthma [17-19].
Poorly controlled symptoms of allergic rhinitis may also contribute
to sleep loss, secondary daytime fatigue, learning impairment,
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decreased long-term productivity and decreased quality of life.
Treatment of allergic rhinitis with sedating antihistamine therapy may
result in poor quality of life [20,21].
The prevalence of allergies in Africa shows a consistent increase
over a period of 7-10 years [22]. In African epidemiological data are
scarce but the overall prevalence of allergic rhinitis in children is at
least 20% to 24% and there is evidence of increasing prevalence [23].
Furthermore many patients do not recognize allergic rhinitis as a
disease and therefore do not consult a physician [24]. This study aimed
at determining the prevalence, sociodemographic features, trigger
factors, clinical features, complications, quality of life, associated co-
morbid illnesses and treatment outcome among children attending
Ekiti state university teaching hospital.
Material and Methods
This was a prospective hospital-based study of children (18 years or
less) with clinical diagnosis of allergy carried out at Ekiti state
university teaching hospital Ado Ekiti, Ekiti state. The study was
carried out over a period of one year from May 2017 to April 2018.
All consecutive patients who presented with features and diagnosis
of allergy to the ear, nose and throat department were enrolled into the
study. Informed consent was obtained from patients/guardian/parents
before patients were enrolled into the study.
The data collection for this study was by pretested self-administered
questionnaire. The information included sociodemographic features,
clinical presentation, duration of symptoms, frequency of symptoms
and triggering factors. Detailed otorhinolaryngological history was
taken from the patients, guardian or parents. Also detailed history on
possible comorbid illnesses, complication, aetiological and
predisposing factor for allergy was taken. Past medical, surgical, family
and social history were taken. All the patients had general physical and
systemic examination done. A thorough ear, throat, nose, head and
neck examination was done and documented. Radiological
investigations such as plain X ray and computerised tomographic scan
of the paranasal sinuses were requested based on clinical findings.
Haematological test looking for eosinophilia and nasal smear for
cytology were carried out. Patient subsequently had medical, surgical
or combined form of treatment based on their findings. Participants
were followed up in the ear, nose and throat clinic for possible outcome
and complications..
All data obtained were documented, collated and analyzed. The data
analysis was done by using SPSS version 18.0. The analyzed data were
expressed in simple descriptive methods with tables, bar chart and pie
chart.
Ethical approval was considered and obtained from the ethical
committee of the institution.
Results
A total of 2167 patients were seen in the ENT department over the
study period. There were 186 consented paediatric patients with allergy
enrolled into the study. Prevalence of allergy in children in this study
was 8.6%.
Allergy affects all the paediatric age group with peaked age group at
preschool age group (1-5 years) with prevalence of 38.2%. This is
demonstrated in Figure 1.
There were 112 (60.2%) male and 74 (39.8%) female with male to
female ratio of 1.5:1. 83 (44.6%) were living in various cities while 49
(26.3%) were from villages. Majority 71 (38.2%) were nursery pupil, 52
(28.0%) are secondary education level while 47 (25.3%) were primary
education level. Parent’s occupations were 53 (28.5%) farming, 51
(27.4%) teaching and 38 (20.4%) business. This is illustrated in Table 1.
There were positive family history of allergy in 104 (55.9%) patients
and there were no family history of allergy in 82 (44.1%) patients.
Perennial allergy in 127 (68.3%) were commoner than seasonal allergy
in 59 (31.7%) children. Using ARIA classification majority of the
patients were 121 (65.1%) moderate-severe persistent allergic rhinitis
and 33 (17.7%) moderate-severe intermittent allergic rhinitis. The
minority were of the children were mild intermittent allergic rhinitis
and accounted for 8 (4.3%) of the study population. Major form of
allergens was 133 (71.5%) inhalant and the least form of allergen was
18 (9.7%) ingestant. In this study, self-reported allergy was based on
the trigger factors. The commonest identified trigger factors among the
study population were as follows: dust, cold weather and smoke which
were accounted for 108 (58.1%), 78 (41.9%) and 41 (22.0%) of the
study children respectively. The less common trigger factors were soap
and perfume which accounted for 11 (5.9%) and 16 (8.6%) children
respectively. This is showed in Table 2.
Major associated comorbid illnesses among the children with
allergy in this study were 81 (43.5%) adenotonsillar hypertrophy, 43
(23.1%) inferior turbinate hypertrophy and 38 (20.4%) otitis media
with effusion. Minor associated comorbid illnesses in this study were
allergic dermatitis in 14 (5.3%), sinusitis in 13 (7.0%) and nasal polyps
in 12 (6.5%). This is demonstrated in Table 3.
Common allergic symptoms in this study were runny nose in 72
(38.7%), nasal blockage in 61 (32.8%), recurrent sneezing in 53 (28.5%)
and nasal itching in 43 (23.1%). Other symptoms are 12 (6.5%) ear
water sensation, 17 (9.1%) tearing and 18 (9.7%) eye itching and 19
(10.2%) hoarseness. Symptoms are illustrated in Table 4.
The common clinical findings among the children included
rhinorrhea, hyper pigmented nose, reduced nasal patency and bluish
oedematous mucosa in 78 (41.9%), 61 (32.8%), 44 (23.7%) and 39
(21.0%) respectively. Other findings are 14 (7.5%) retracted tympanic
membrane, 11 (5.9%) red eye, 9 (4.8%) periorbital hyperpigmentation
and 4 (2.2%) head and neck urticaria rashes. Clinical sign among the
children was shown in Table 5.
The commonest affected organ in the head and neck region was
nose in 87 (46.8%). Other affected organs were ear in 46 (24.7%) and
throat in 34 (18.3%). This is illustrated in Figure 2.
Commonly affected quality of life among the children were 42
(22.6%) irritability, 38 (20.4%) absenteeism, 37 (19.9%) sleep
disruption and 24 (12.9%) impaired social life. Others were daytime
sleepiness 8 (4.3%) and memory deficit 9 (4.8%).This is demonstrated
in Table 6.
Common complications which were associated with allergy in this
study were 86 (46.2%) otitis media/externa, 82 (44.1%) injury, 79
(42.5%) foreign body impaction and 75 (40.3%) pharyngitis. Less
common complication of allergy were 23 (12.4%) orbital complication
and 21 (11.3%) pneumonia. This is shown in Figure 3.
Treatment approach was by combination of allergens avoidance,
medical treatment and surgery was reserved for comorbid illnesses and
complications. Treatment of allergy leads to improvement and
recovery on the clinical features in 97 (52.2%) patients. No significant
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improvement in clinical features was noticed in 89 (47.8%) patients.
None of the studied patients reported worse clinical condition after
treatment of allergy. No mortality was recorded from allergy, comorbid
illnesses, complications or treatment intervention in our study.
Figure 1: Age group distribution of patients.
Sociodemographic
features
Number Percentage (%)
Sex
Male 112 60.2
Female 74 39.8
Residential
City 83 44.6
Town 54 29
Village 49 26.3
Education level
Nursery 71 38.2
Primary 47 25.3
Secondary 52 28
Post-secondary 16 8.6
Parental occupation
Business 38 20.4
Teaching 51 27.4
Industrial worker 27 14.8
Farming 53 28.5
Health worker 17 9.1
Table 1: Sociodemographic features of the patients (N=186).
Features of Allergy Number Percentage (%)
Family history of Allergy
Present 104 55.9
Absent 82 44.1
Type of Allergy
Perennial 127 68.3
Seasonal 59 31.7
ARIA Classification
Mild-Intermittent 8 4.3
Moderate-Severe intermittent 33 17.7
Mild-Persistent 24 12.9
Moderate-Severe Persistent 121 65.1
Form of Allergy
Inhalant 133 71.5
Ingestant 18 9.7
Contactant 35 18.8
Trigger factor
Dust 108 58.1
Cold weather 78 41.9
Smoke 41 22
Perfume 16 8.6
Vehicle exhaust 24 12.9
Soap 11 5.9
Table 2: Features of Allergy among the patients (N=186).
Comorbid illnesses Number Percentage (%)
Asthma 23 12.4
Otitis media with effusion 38 20.4
Allergic dermatitis 14 7.5
Recurrent tonsillitis 34 18.3
Adenotonsillar hypertrophy 81 43.5
Inferior turbinate
hypertrophy
43 23.1
Nasal polyps 12 6.5
Ear discharge 22 11.8
Sinusitis 13 7
NB: Some patients has more than one comorbid illness.
Table 3: Comorbid illnesses.
Symptoms Number Percentage (%)
Blocked nose 61 32.8
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Runny nose 72 38.7
Recurrent sneezing 53 28.5
Nasal itching 43 23.1
Itchy throat 31 16.7
Cough 38 20.4
Post nasal drip 20 10.8
Hoarseness 19 10.2
Sore throat 26 14
Itchy ear 37 19.9
Ear blockage 36 19.4
Ear water sensation 12 6.5
Earache 21 11.3
Tearing 17 9.1
Eye itching 18 9.7
NB : Some patients has more than one symptoms
Table 4: Otorhinolaryngological symptoms among the patients.
Signs Number Percentage (%)
Bluish oedematous
mucosa
39 21
Enlarged turbinate 37 19.9
Rhinorrhea 78 41.9
Hyperpigmented nose 61 32.8
Reduced nasal patency 44 23.7
Dull tympanic membrane 23 12.4
Retracted tympanic
membrane
14 7.5
Enlarged tonsils 21 11.3
Red eye 11 5.9
Periorbital
hyperpigmentation
9 4.8
Head and neck urticaria
rashes
4 2.2
NB: Some patients presented with more than one clinical signs.
Table 5: Otorhinolaryngological clinical signs among the patients.
Figure 2: Otorhinolaryngological distribution of allergy.
Quality of life Number Percentage (%)
Impaired social life 24 12.9
Sleep disruption 37 19.9
Fatigue 13 7
Daytime sleepiness 8 4.3
Irritability 42 22.6
Memory deficit 9 4.8
Absenteeism 38 20.4
NB: Some patients has more than one complications.
Table 6: Quality of life among the children.
Figure 3: Complications of allergy among patients.
Discussion
Allergic disorder in children is a global healthy problem and under-
diagnosed because the symptoms are frequently attributed to infection.
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As a result of this most parents use available medication or local herbs
without doctor’s prescription and such treatment are suboptimal [25].
In this study prevalence of allergy in children was 8.6%. This is
lower than prevalence rate in other previous study on nasal allergy [7].
This low prevalence of allergy may be due to under presentation for
specialist care as majority of allergic disorder were treated by their
family physician or paediatrician. Referred cases to
otorhinolaryngologist, head and neck surgeon were severe,
complicated or when associated with co-morbid illnesses. Studies in
developed part of the world also revealed higher prevalence of nasal
allergic disorder [26,27]. Higher prevalence were also reported in some
developing country in African countries includes 29.6% in Nigeria and
30% in Cape Town in South Africa [28,29]. Factors responsible for
high prevalence of allergy in children include climatic factors, dietary
changes; environmental factors and industrial pollution were reported
in this study.
There was male preponderance in this study. This observation was
in agreement with other study by Alsowaidi et al. [30]. This is different
from Brazilian study with female preponderance [31]. Study in Kenyan
reported equal sex preponderance [32]. Gender parity findings may
likely be by chance.
Environmental factors were responsible for increased risk of allergy
among children in this study were dusts, fumes exhausts from vehicle,
environmental tobacco smoke exposure and moulds and perfume. This
is similar to findings on studies on risks factors of allergic rhinitis
[33,34]. There was family history of allergic disorder among majority
of children in this study. A similar finding was reported by Herr et al.
in their study [35].
Inflammation of the various in the head and neck mucosal lining
and contiguous structure from allergens results in different kind of
clinical features. These features are recurrent sneezing, rhinorrhoea,
nasal congestion, ear water sensation, tearing and itching in the ear;
nose, throat, eyes, head and neck were also reported in other study
[36]. In this study, high percentage of patients had runny nose
(rhinorrhoea), nasal blockage, bout of sneezing, hyper pigmented nose,
reduced nasal patency and bluish oedematous mucosa and these
findings are similar to other studies on allergic rhinitis [37].
In this study of allergy in children there are associated significant
comorbid illnesses such as asthma, sinusitis, otitis media, adenoid
hypertrophy and allergic conjunctivitis. This is similar to findings by
Hardojo et al. in its study on allergic rhinitis in children [25].
Clinical features of allergy among children such as bout of sneezing,
pruritus, rhinorrhoea and nasal obstruction grossly affected quality of
life of children in this study. Quality of life that are often affected
includes impaired social life, sleep disruption, fatigue, daytime
sleepiness, irritability, memory deficit, effect on daily activities such as
playing, working and absenteeism [37]. Nasal obstruction and nasal
congestion were responsible for the sleep disturbances [37,38].
The two key steps in the process of allergy diagnosis are the medical
history and allergy test selection. Medical history is the critical link
between allergy test results and allergic disease itself. Although, both
blood and skin allergy tests can detect a patient’s sensitivity to common
inhalants like pollen and dust mites or to medicines, certain foods,
latex, venom, or other substances, the allergy skin testing is however
the gold standard and is used along with the medical history to
establish a diagnosis [39]. If the results of skin and blood allergy tests
are not clear or are inconsistent with the patient’s medical history,
allergists rely on their training and experience along with a patient’s
medical history and a physical examination to make the final
diagnosis.
Complications of allergy occur when the mucosal lining of an organ
is bridged. Associated complications of allergy in this study include
otitis media and external, pharyngitis, Injury to the external auditory
canal from persistent scratching, foreign body impaction like cotton
bud and orbital complications. This finding is similar to the reports in
previous study [40].
In the management of the allergic patients, multidisciplinary
approach was used in this study. This is due to associated comorbid
illnesses and complication of allergy in children. The health team
included general practitioner, paediatricians, ophthalmologist,
dermatologist and otorhinolaryngologists, head and neck surgeon [23].
The treatments of approach were allergen avoidance, medical
intervention and surgical treatment of comorbid illnesses and
complications. Allergens control requires aggressive environmental
control which is effective [41]. Medical treatment includes
antihistamines and intranasal steroid depending on the clinical
findings. Surgical therapy is reserved for adequate treatment of
comorbid illnesses, complications and refractory to medical treatment
[42]. Other form treatments such as Immunotherapy, desensitization
are not used in this study due to available facilities in our study center
[43].
There is no associated mortality to allergy in children in our
findings. Common cause of death due to comorbid illnesses, surgical
complications were recorded in other study [44].
Limitation of this study includes inability to performed allergy
testing, the study is a hospital based study and measurement of quality
of life without the use of standardized and validated (generic or
disease-related) questionnaires. Despite these limitations this study
provide hospital information which can serve as bases for community
based study and may help health care workers to develop guideline in
management of allergy in children.
Conclusion
Allergy is very common and affects ear, nose, throat, head and neck
organs. It is usually neglected with late presentation in children. At
presentation there were associated comorbid illnesses, complications
and affectation of quality of life to the otorhinolaryngologist in
majority of the children. Early referral is highly recommended to the
specialist to avoid on toward effect. There is urgent need to increase
level of awareness and health education of the people on allergy.
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